PDS Biotechnology Corp.
(NASDAQ : PDSB)

( )
PDSB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.28%41.590.9%$960.31m
MRKMerck & Co., Inc.
0.19%78.870.6%$778.33m
JNJJohnson & Johnson
-0.15%138.400.7%$769.00m
BMYBristol-Myers Squibb Company
-1.20%46.291.4%$656.79m
LLYEli Lilly and Company
0.18%116.221.0%$521.76m
ABBVAbbVie, Inc.
0.44%79.812.2%$446.60m
NVSNovartis AG Sponsored ADR
-0.82%82.020.2%$208.94m
AZNAstraZeneca PLC Sponsored ADR
-0.64%37.541.3%$189.73m
GSKGlaxoSmithKline plc Sponsored ADR
-0.20%39.380.2%$99.07m
NVONovo Nordisk A/S Sponsored ADR Class B
0.98%47.250.1%$62.93m
SNYSanofi Sponsored ADR
-1.12%41.430.2%$47.37m
LCILannett Company, Inc.
0.00%6.0036.7%$10.13m
AKTXAkari Therapeutics Plc Sponsored ADR
-4.71%2.631.6%$3.88m
EPIXESSA Pharma Inc
0.94%2.160.1%$0.01m

Company Profile

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded on March 15, 2019 and is headquartered in Berkeley Heights, NJ.